Pub Date : 2025-11-07DOI: 10.1016/j.ahjo.2025.100667
Aimen Shafiq , Ali Salman , Sadia Akram , Muhammad Rizwan Farooq , Qais Bin Abdul Ghaffar , Anam Ijaz , Abdullah Imtiaz , Humna Irshad , Aroon Kumar , Muhammad Faisal Riaz , Saman Rauf , Usman Sarwar , Kaneez Fatima , Ali Hasan , Raheel Ahmed
Background
Palliative care consultation (PCC) in acute decompensated heart failure (ADHF) may enhance care quality and align treatment with patient goals. However, national trends and predictors of PCC in ADHF remain poorly defined.
Methods
We used the National Inpatient Sample (2018–2020) to identify hospitalizations for adults (≥18 years) with a primary diagnosis of ADHF using ICD-10-CM codes. PCC was defined by ICD-10-CM code Z51.5. Multivariable survey-weighted logistic regression identified predictors of PCC use, adjusting for demographics, socioeconomic status, comorbidities, and hospital factors.
Results
Among 3,655,265 hospitalizations, older age was associated with higher odds of PCC (aOR 1.05 per year; 95 % CI, 1.05–1.05). Compared to White individuals, odds of PCC were lower for Asian or Pacific Islander (aOR 0.74), Black (aOR 0.83), and Hispanic individuals (aOR 0.76). Medicare patients had lower odds than those with Medicaid (aOR 0.72). The highest income quartile was associated with greater PCC use (aOR 1.18). PCC was less common in the Northeast (aOR 0.88), South (aOR 0.93), and West (aOR 0.91) compared to the Midwest. Urban teaching hospitals had higher PCC rates than rural hospitals (aOR 1.48). Patients with greater comorbidity and higher mortality risk were more likely to receive PCC.
Conclusion
PCC use in ADHF is influenced by demographic, socioeconomic, clinical, and institutional factors. Racial, regional, and hospital-level disparities suggest a need for interventions to promote equitable access to palliative care for patients with ADHF.
{"title":"Patterns and predictors of palliative care use in acute heart failure hospitalizations","authors":"Aimen Shafiq , Ali Salman , Sadia Akram , Muhammad Rizwan Farooq , Qais Bin Abdul Ghaffar , Anam Ijaz , Abdullah Imtiaz , Humna Irshad , Aroon Kumar , Muhammad Faisal Riaz , Saman Rauf , Usman Sarwar , Kaneez Fatima , Ali Hasan , Raheel Ahmed","doi":"10.1016/j.ahjo.2025.100667","DOIUrl":"10.1016/j.ahjo.2025.100667","url":null,"abstract":"<div><h3>Background</h3><div>Palliative care consultation (PCC) in acute decompensated heart failure (ADHF) may enhance care quality and align treatment with patient goals. However, national trends and predictors of PCC in ADHF remain poorly defined.</div></div><div><h3>Methods</h3><div>We used the National Inpatient Sample (2018–2020) to identify hospitalizations for adults (≥18 years) with a primary diagnosis of ADHF using ICD-10-CM codes. PCC was defined by ICD-10-CM code Z51.5. Multivariable survey-weighted logistic regression identified predictors of PCC use, adjusting for demographics, socioeconomic status, comorbidities, and hospital factors.</div></div><div><h3>Results</h3><div>Among 3,655,265 hospitalizations, older age was associated with higher odds of PCC (aOR 1.05 per year; 95 % CI, 1.05–1.05). Compared to White individuals, odds of PCC were lower for Asian or Pacific Islander (aOR 0.74), Black (aOR 0.83), and Hispanic individuals (aOR 0.76). Medicare patients had lower odds than those with Medicaid (aOR 0.72). The highest income quartile was associated with greater PCC use (aOR 1.18). PCC was less common in the Northeast (aOR 0.88), South (aOR 0.93), and West (aOR 0.91) compared to the Midwest. Urban teaching hospitals had higher PCC rates than rural hospitals (aOR 1.48). Patients with greater comorbidity and higher mortality risk were more likely to receive PCC.</div></div><div><h3>Conclusion</h3><div>PCC use in ADHF is influenced by demographic, socioeconomic, clinical, and institutional factors. Racial, regional, and hospital-level disparities suggest a need for interventions to promote equitable access to palliative care for patients with ADHF.</div></div>","PeriodicalId":72158,"journal":{"name":"American heart journal plus : cardiology research and practice","volume":"61 ","pages":"Article 100667"},"PeriodicalIF":1.8,"publicationDate":"2025-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145684870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-04DOI: 10.1016/j.ahjo.2025.100662
Rene Labounek , Matti J. Matheson , Ashley J. Petersen , Adam Hansen , Adam D. Block , Corey Strong Jr , Annamarie Hill , Meghan Kremer , Ann J. Robertson , Valmiki Maharaj , Kamakshi Lakshminaryan , Danni Li , J. Neil Henderson , Igor Nestrasil , Christophe Lenglet , William G. Mantyh
Objective
American Indian/Indigenous (AI) populations have the highest rate of ischemic heart disease (IHD) of any racial or ethnic group in the United States. While modifiable cardiovascular risk factors represent a well-established source of elevated IHD in AI, little is known regarding genetic IHD influences, in particular APOE ε4, which has an ancestry-dependent prevalence and effect on human disease. We sought to quantify the prevalence and association between APOE ε4 and IHD in AI communities.
Methods
We performed a cross-sectional, community-based study including tribal Elders (ages >54 years) at the Bois Forte Band of Chippewa in the state of Minnesota. We collected data pertaining to demographics, cardiovascular risk factors, APOE ε4 genotype, and ischemic heart disease (defined as history of myocardial infarction, coronary artery bypass graft, angiogram showing coronary artery disease, percutaneous transluminal coronary angioplasty, or thrombolytic therapy).
Findings
One-hundred-eighty-one participants were included. Their median age and interquartile range were 67 (61, 73) years, AI ancestry was 75 % (50 %, 100 %), 126 (70 %) were females, 46 (25 %) were APOE ε4 heterozygous, and 5 (2.8 %) were APOE ε4 homozygous. Each APOE ε4 allele increased the odds of IHD in AI tribal Elders 2.38-fold (95 % CI: 0.94–6.89; p = 0.06), which is comparable to a two-point rise in hemoglobin A1C.
Conclusions
APOE ε4 appears to play an important role in the risk of IHD in AI populations, given its high prevalence and strong association with IHD.
目的美洲印第安人/土著(AI)人口是美国所有种族或民族中缺血性心脏病(IHD)发病率最高的。虽然可改变的心血管危险因素代表了AI中IHD升高的一个公认的来源,但对于遗传性IHD的影响知之甚少,特别是APOE ε4,它具有依赖于祖先的患病率和对人类疾病的影响。我们试图量化APOE ε4和IHD在AI社区的患病率和相关性。方法我们在明尼苏达州Chippewa Bois Forte部落进行了一项以社区为基础的横断面研究,其中包括部落长老(54岁)。我们收集了有关人口统计学、心血管危险因素、APOE ε4基因型和缺血性心脏病(定义为心肌梗死史、冠状动脉搭桥术、血管造影显示冠状动脉疾病、经皮腔内冠状动脉成形术或溶栓治疗)的数据。研究结果共纳入181名参与者。年龄中位数和四分位数范围为67(61,73)岁,AI祖先75%(50%,100%),女性126 (70%),APOE ε4杂合46 (25%),APOE ε4纯合5(2.8%)。每个APOE ε4等位基因使AI部落长者患IHD的几率增加2.38倍(95% CI: 0.94-6.89; p = 0.06),相当于血红蛋白A1C升高2个点。结论鉴于apoe ε4的高流行率和与IHD的强相关性,apoe ε4可能在AI人群IHD发病风险中起重要作用。
{"title":"APOE ε4 and ischemic heart disease in American Indian/Indigenous tribal Elders","authors":"Rene Labounek , Matti J. Matheson , Ashley J. Petersen , Adam Hansen , Adam D. Block , Corey Strong Jr , Annamarie Hill , Meghan Kremer , Ann J. Robertson , Valmiki Maharaj , Kamakshi Lakshminaryan , Danni Li , J. Neil Henderson , Igor Nestrasil , Christophe Lenglet , William G. Mantyh","doi":"10.1016/j.ahjo.2025.100662","DOIUrl":"10.1016/j.ahjo.2025.100662","url":null,"abstract":"<div><h3>Objective</h3><div>American Indian/Indigenous (AI) populations have the highest rate of ischemic heart disease (IHD) of any racial or ethnic group in the United States. While modifiable cardiovascular risk factors represent a well-established source of elevated IHD in AI, little is known regarding genetic IHD influences, in particular <em>APOE ε4</em>, which has an ancestry-dependent prevalence and effect on human disease. We sought to quantify the prevalence and association between <em>APOE ε4</em> and IHD in AI communities.</div></div><div><h3>Methods</h3><div>We performed a cross-sectional, community-based study including tribal Elders (ages >54 years) at the Bois Forte Band of Chippewa in the state of Minnesota. We collected data pertaining to demographics, cardiovascular risk factors, <em>APOE ε4</em> genotype, and ischemic heart disease (defined as history of myocardial infarction, coronary artery bypass graft, angiogram showing coronary artery disease, percutaneous transluminal coronary angioplasty, or thrombolytic therapy).</div></div><div><h3>Findings</h3><div>One-hundred-eighty-one participants were included. Their median age and interquartile range were 67 (61, 73) years, AI ancestry was 75 % (50 %, 100 %), 126 (70 %) were females, 46 (25 %) were <em>APOE ε4</em> heterozygous, and 5 (2.8 %) were <em>APOE ε4</em> homozygous. Each <em>APOE ε4</em> allele increased the odds of IHD in AI tribal Elders 2.38-fold (95 % CI: 0.94–6.89; <em>p</em> = 0.06), which is comparable to a two-point rise in hemoglobin A1C.</div></div><div><h3>Conclusions</h3><div><em>APOE ε4</em> appears to play an important role in the risk of IHD in AI populations, given its high prevalence and strong association with IHD.</div></div>","PeriodicalId":72158,"journal":{"name":"American heart journal plus : cardiology research and practice","volume":"60 ","pages":"Article 100662"},"PeriodicalIF":1.8,"publicationDate":"2025-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145467523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
To determine the incidence and predictors of unplanned 30-day readmission and in-hospital mortality among adults hospitalized with AHF in Ethiopia.
Methods
A multicenter prospective observational study was conducted in six referral hospitals in the Amhara region between December 2023 and April 2024. Adults (≥18 years) with AHF were consecutively enrolled and followed up until discharge and 30 days post-discharge. Kaplan–Meier survival analysis and Cox regression were used to estimate outcomes and predictors.
Results
Of the 1131 patients, 275 (24.4 %) were readmitted within 30 days and 121 (10.7 %) died in the hospital. Independent predictors of readmission included hyponatremia (AHR = 10.5; 95 % CI: 3.1–36.2), thrombocytopenia (AHR = 16.7; 95 % CI: 4.8–58.3), ischemic heart disease (AHR = 6.9; 95 % CI: 1.8–27.0), Charlson Comorbidity Index ≥4 (AHR = 6.5; 95 % CI: 1.7–24.6), poor physician adherence to guideline-directed therapy (AHR = 8.2; 95 % CI: 2.3–30.1), and low patient adherence (AHR = 4.8; 95 % CI: 1.6–14.5). Prescription of ACE inhibitors, beta-blockers, and SGLT2 inhibitors at discharge significantly reduced the readmission risk (AHR range: 0.09–0.30). The predictors of in-hospital mortality included reduced ejection fraction, tachycardia, hypoxemia, left bundle branch block, pulmonary hypertension, elevated creatinine, severe hypertension, and pneumonia.
Conclusion
AHF patients in Ethiopia experience high short-term readmission and mortality. Correcting electrolyte imbalances, improving comorbidity management, strengthening physician adherence to guideline-directed therapy, and promoting patient adherence are essential for improving outcomes.
{"title":"Short-term outcomes of acute heart failure hospitalizations in Ethiopia: A multicenter prospective study","authors":"Getachew Yitayew Tarekegn , Legesse Chekleba , Tilaye Arega Moges , Fisseha Nigussie Dagnew , Samuel Berihun Dagnew , Sisay Stiotaw Anberbr , Behailu Terefe Tesfaye","doi":"10.1016/j.ahjo.2025.100665","DOIUrl":"10.1016/j.ahjo.2025.100665","url":null,"abstract":"<div><h3>Objectives</h3><div>To determine the incidence and predictors of unplanned 30-day readmission and in-hospital mortality among adults hospitalized with AHF in Ethiopia.</div></div><div><h3>Methods</h3><div>A multicenter prospective observational study was conducted in six referral hospitals in the Amhara region between December 2023 and April 2024. Adults (≥18 years) with AHF were consecutively enrolled and followed up until discharge and 30 days post-discharge. Kaplan–Meier survival analysis and Cox regression were used to estimate outcomes and predictors.</div></div><div><h3>Results</h3><div>Of the 1131 patients, 275 (24.4 %) were readmitted within 30 days and 121 (10.7 %) died in the hospital. Independent predictors of readmission included hyponatremia (AHR = 10.5; 95 % CI: 3.1–36.2), thrombocytopenia (AHR = 16.7; 95 % CI: 4.8–58.3), ischemic heart disease (AHR = 6.9; 95 % CI: 1.8–27.0), Charlson Comorbidity Index ≥4 (AHR = 6.5; 95 % CI: 1.7–24.6), poor physician adherence to guideline-directed therapy (AHR = 8.2; 95 % CI: 2.3–30.1), and low patient adherence (AHR = 4.8; 95 % CI: 1.6–14.5). Prescription of ACE inhibitors, beta-blockers, and SGLT2 inhibitors at discharge significantly reduced the readmission risk (AHR range: 0.09–0.30). The predictors of in-hospital mortality included reduced ejection fraction, tachycardia, hypoxemia, left bundle branch block, pulmonary hypertension, elevated creatinine, severe hypertension, and pneumonia.</div></div><div><h3>Conclusion</h3><div>AHF patients in Ethiopia experience high short-term readmission and mortality. Correcting electrolyte imbalances, improving comorbidity management, strengthening physician adherence to guideline-directed therapy, and promoting patient adherence are essential for improving outcomes.</div></div>","PeriodicalId":72158,"journal":{"name":"American heart journal plus : cardiology research and practice","volume":"60 ","pages":"Article 100665"},"PeriodicalIF":1.8,"publicationDate":"2025-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145467526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Neurocognitive dysfunction is a common but often overlooked complication in patients with Acute Coronary Syndrome (ACS). This narrative review aims to provide a comprehensive synthesis of current evidence on the prevalence, mechanisms, clinical assessment, and management strategies of cognitive impairment in ACS patients. We highlight how neurocognitive deficits including memory loss, reduced attention, and executive dysfunction arise from cerebral hypoperfusion, systemic inflammation, microvascular injury, and post-infarct metabolic stress. These deficits arise from mechanisms including cerebral hypoperfusion, systemic inflammation, microvascular injury, and post-infarct metabolic stress. Such impairments are associated with poorer clinical outcomes, decreased treatment adherence, and increased mortality.
Routine cognitive assessment remains absent from standard ACS management, despite the availability of effective tools such as the Montreal Cognitive Assessment (MoCA), which can detect subtle cognitive deficits early in hospitalization. Integrating cognitive screening into clinical protocols enables timely interventions and better patient stratification. Management strategies should combine pharmacological treatment of cardiovascular risk factors with non-pharmacological interventions such as cognitive rehabilitation, mental health support, and lifestyle modification. Multidisciplinary collaboration between cardiology, neurology, psychology, and rehabilitation specialists is essential to address both cardiac and cognitive recovery.
By integrating findings from clinical and epidemiological studies, this review underscores the need for routine cognitive screening, multidisciplinary care, and innovative interventions such as telemedicine to improve patient outcomes. Recognizing cognitive health as an integral part of ACS management offers a more holistic, patient-centered approach to recovery.
{"title":"Cognition and coronary events: A narrative overview of neurocognitive impairment in ACS patients","authors":"Umaimah Batool Mirza , Faareah Mansoor , Umna Fnu , Summiya Riaz , Mehar Zaka , Ahmed Asad Raza , Abedin Samadi","doi":"10.1016/j.ahjo.2025.100666","DOIUrl":"10.1016/j.ahjo.2025.100666","url":null,"abstract":"<div><div>Neurocognitive dysfunction is a common but often overlooked complication in patients with Acute Coronary Syndrome (ACS). This narrative review aims to provide a comprehensive synthesis of current evidence on the prevalence, mechanisms, clinical assessment, and management strategies of cognitive impairment in ACS patients. We highlight how neurocognitive deficits including memory loss, reduced attention, and executive dysfunction arise from cerebral hypoperfusion, systemic inflammation, microvascular injury, and post-infarct metabolic stress. These deficits arise from mechanisms including cerebral hypoperfusion, systemic inflammation, microvascular injury, and post-infarct metabolic stress. Such impairments are associated with poorer clinical outcomes, decreased treatment adherence, and increased mortality.</div><div>Routine cognitive assessment remains absent from standard ACS management, despite the availability of effective tools such as the Montreal Cognitive Assessment (MoCA), which can detect subtle cognitive deficits early in hospitalization. Integrating cognitive screening into clinical protocols enables timely interventions and better patient stratification. Management strategies should combine pharmacological treatment of cardiovascular risk factors with non-pharmacological interventions such as cognitive rehabilitation, mental health support, and lifestyle modification. Multidisciplinary collaboration between cardiology, neurology, psychology, and rehabilitation specialists is essential to address both cardiac and cognitive recovery.</div><div>By integrating findings from clinical and epidemiological studies, this review underscores the need for routine cognitive screening, multidisciplinary care, and innovative interventions such as telemedicine to improve patient outcomes. Recognizing cognitive health as an integral part of ACS management offers a more holistic, patient-centered approach to recovery.</div></div>","PeriodicalId":72158,"journal":{"name":"American heart journal plus : cardiology research and practice","volume":"60 ","pages":"Article 100666"},"PeriodicalIF":1.8,"publicationDate":"2025-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145520839","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-30DOI: 10.1016/j.ahjo.2025.100663
Tamás Ferenci , András Jánosi
Study Objective
Despite advances, myocardial infarction remains a significant public health concern, with survival being a crucial outcome measure. While all-cause mortality is well-studied, less is known about causes of death following an infarction. This study aimed to analyse cause-specific mortality after myocardial infarction and to compare it with the analysis of all-cause mortality.
Design
Data from a nationwide Hungarian myocardial infarction registry from January 2020 to June 2022 were linked with official cause of death information. Cumulative incidence functions and multivariable modelling of subdistribution hazard were used for cause-specific survival analysis, accounting for competing risks. Standard all-cause survival analysis (Cox proportional hazards model) was also carried out as a comparison.
Results
Among 27,965 patients with acute myocardial infarction, 25.0 % died during follow-up (of a median of 661 days). Myocardial infarction was the primary cause of death in 38.6 % of cases, followed by other cardiovascular causes (37.5 %). Factors associated with higher cause-specific mortality for infarction included older age, male sex, ST-elevation infarction, diabetes, prior stroke, peripheral artery disease, and heart failure. Percutaneous coronary intervention and hypertension was associated with lower hazard. Results largely matched all-cause survival analysis, except for ST-elevation, where hazard was much higher in cause-specific analysis.
Conclusions
While overall and cause-specific analyses aligned in this large registry study, a notable difference was observed for ST-elevation infarction, where hazard was substantially higher in the cause-specific analysis. This highlights the potential relevance of distinguishing between causes of death for a more precise understanding of outcomes.
{"title":"Comparison of all-cause and cause-specific mortality after myocardial infarction – a Hungarian registry study","authors":"Tamás Ferenci , András Jánosi","doi":"10.1016/j.ahjo.2025.100663","DOIUrl":"10.1016/j.ahjo.2025.100663","url":null,"abstract":"<div><h3>Study Objective</h3><div>Despite advances, myocardial infarction remains a significant public health concern, with survival being a crucial outcome measure. While all-cause mortality is well-studied, less is known about causes of death following an infarction. This study aimed to analyse cause-specific mortality after myocardial infarction and to compare it with the analysis of all-cause mortality.</div></div><div><h3>Design</h3><div>Data from a nationwide Hungarian myocardial infarction registry from January 2020 to June 2022 were linked with official cause of death information. Cumulative incidence functions and multivariable modelling of subdistribution hazard were used for cause-specific survival analysis, accounting for competing risks. Standard all-cause survival analysis (Cox proportional hazards model) was also carried out as a comparison.</div></div><div><h3>Results</h3><div>Among 27,965 patients with acute myocardial infarction, 25.0 % died during follow-up (of a median of 661 days). Myocardial infarction was the primary cause of death in 38.6 % of cases, followed by other cardiovascular causes (37.5 %). Factors associated with higher cause-specific mortality for infarction included older age, male sex, ST-elevation infarction, diabetes, prior stroke, peripheral artery disease, and heart failure. Percutaneous coronary intervention and hypertension was associated with lower hazard. Results largely matched all-cause survival analysis, except for ST-elevation, where hazard was much higher in cause-specific analysis.</div></div><div><h3>Conclusions</h3><div>While overall and cause-specific analyses aligned in this large registry study, a notable difference was observed for ST-elevation infarction, where hazard was substantially higher in the cause-specific analysis. This highlights the potential relevance of distinguishing between causes of death for a more precise understanding of outcomes.</div></div>","PeriodicalId":72158,"journal":{"name":"American heart journal plus : cardiology research and practice","volume":"60 ","pages":"Article 100663"},"PeriodicalIF":1.8,"publicationDate":"2025-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145467525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-30DOI: 10.1016/j.ahjo.2025.100660
Thang Nguyen Ngoc , Le Nguyen Thi Nhat , An Pham Van , Soan Hoang Thu , Nghia Nguyen Minh , Thang Vu Tien , Hong Le Thi Bich , Hung Tran Viet , Huyen Pham Thi Thu , Nhung Do Phuong , Linh Tran Thi Thuy , Le Dao Phuong , Cuong Duong Cao , Long Nguyen , Ngoc Nguyen Minh , Chi Do Thi Kim , Hien Nguyen Thu , Huyen Nguyen Thi Thu
Study objective
To establish sex-specific electrocardiographic (ECG) reference values in healthy Vietnamese late adolescents and characterize sex-based differences in repolarization patterns.
Design
Cross-sectional observational study.
Setting
University health screening program in Vietnam.
Participants
A total of 5127 first-year university students (58.6 % female; age 17–29 years), all asymptomatic and without known cardiovascular or metabolic disease.
Interventions
None.
Main outcome measures
Standard ECG parameters (heart rate, PR interval, QRS duration, QTc, QRST angle), J-point elevation, ST-segment amplitude, and T-wave morphology in leads V1–V6, stratified by sex.
Results
Significant sex differences were observed in all ECG parameters (p < 0.001). Females had higher heart rates (83 vs. 80 bpm), shorter PR intervals (138 vs. 140 ms), and longer QTc intervals (423 vs. 406 ms), while males showed longer QRS durations (90 vs. 80 ms) and narrower QRST angles. In precordial leads, males exhibited higher J-point and ST-segment amplitudes, especially in V2–V3, with the 98th percentile of ST60V2 reaching 0.40 mV. Anterior T-wave inversion (TWI) was more common in females, notably in V1 (71.3 % vs. 48.1 %) and V2 (2.5 % vs. 0.9 %). TWI beyond V2 was rare in both sexes.
Conclusion
This is the first large-scale study to define sex-specific ECG reference values in a Vietnamese cohort. Marked differences in repolarization patterns emphasize the importance of ethnicity- and sex-specific criteria to enhance diagnostic accuracy and avoid misinterpretation in Southeast Asian populations.
{"title":"Electrocardiographic Profiles by sex in a cohort of healthy Vietnamese university students","authors":"Thang Nguyen Ngoc , Le Nguyen Thi Nhat , An Pham Van , Soan Hoang Thu , Nghia Nguyen Minh , Thang Vu Tien , Hong Le Thi Bich , Hung Tran Viet , Huyen Pham Thi Thu , Nhung Do Phuong , Linh Tran Thi Thuy , Le Dao Phuong , Cuong Duong Cao , Long Nguyen , Ngoc Nguyen Minh , Chi Do Thi Kim , Hien Nguyen Thu , Huyen Nguyen Thi Thu","doi":"10.1016/j.ahjo.2025.100660","DOIUrl":"10.1016/j.ahjo.2025.100660","url":null,"abstract":"<div><h3>Study objective</h3><div>To establish sex-specific electrocardiographic (ECG) reference values in healthy Vietnamese late adolescents and characterize sex-based differences in repolarization patterns.</div></div><div><h3>Design</h3><div>Cross-sectional observational study.</div></div><div><h3>Setting</h3><div>University health screening program in Vietnam.</div></div><div><h3>Participants</h3><div>A total of 5127 first-year university students (58.6 % female; age 17–29 years), all asymptomatic and without known cardiovascular or metabolic disease.</div></div><div><h3>Interventions</h3><div>None.</div></div><div><h3>Main outcome measures</h3><div>Standard ECG parameters (heart rate, PR interval, QRS duration, QTc, QRST angle), J-point elevation, ST-segment amplitude, and T-wave morphology in leads V1–V6, stratified by sex.</div></div><div><h3>Results</h3><div>Significant sex differences were observed in all ECG parameters (<em>p</em> < 0.001). Females had higher heart rates (83 vs. 80 bpm), shorter PR intervals (138 vs. 140 ms), and longer QTc intervals (423 vs. 406 ms), while males showed longer QRS durations (90 vs. 80 ms) and narrower QRST angles. In precordial leads, males exhibited higher J-point and ST-segment amplitudes, especially in V2–V3, with the 98th percentile of ST60V2 reaching 0.40 mV. Anterior T-wave inversion (TWI) was more common in females, notably in V1 (71.3 % vs. 48.1 %) and V2 (2.5 % vs. 0.9 %). TWI beyond V2 was rare in both sexes.</div></div><div><h3>Conclusion</h3><div>This is the first large-scale study to define sex-specific ECG reference values in a Vietnamese cohort. Marked differences in repolarization patterns emphasize the importance of ethnicity- and sex-specific criteria to enhance diagnostic accuracy and avoid misinterpretation in Southeast Asian populations.</div></div>","PeriodicalId":72158,"journal":{"name":"American heart journal plus : cardiology research and practice","volume":"60 ","pages":"Article 100660"},"PeriodicalIF":1.8,"publicationDate":"2025-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145467524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-30DOI: 10.1016/j.ahjo.2025.100659
Jimmy Kang , Ryaan El-Andari , Nicholas Fialka , Yongzhe Hong , Michael S. McMurtry , Jeevan Nagendran , Jayan Nagendran
Objective
The optimal revascularization strategy for patients with three-vessel coronary artery disease (3VD) and heart failure (HF) remains uncertain due to the absence of randomized trials directly comparing coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI). With few observational studies providing long-term follow-up, clinical equipoise persists. We therefore evaluated 10-year outcomes between CABG and PCI in patients with HF and 3VD.
Methods
This retrospective population-based cohort study included adults with 3VD and HF undergoing isolated CABG or PCI in Edmonton, Alberta, Canada (2009–2018). Patients with STEMI, prior CABG, or concomitant procedures were excluded. The primary endpoint was all-cause mortality. Secondary endpoints included readmission for myocardial infarction (MI), stroke, repeat revascularization, and all-cause rehospitalization. Multivariable Cox regression was used to adjust for baseline characteristics.
Results
Of 1774 screened patients, 632 met inclusion criteria (CABG: n = 97; PCI: n = 535). At 10 years, all-cause mortality was significantly lower in the CABG group (62.4 %) compared to PCI (71.8 %) (adjusted hazard ratio [aHR] 0.65, 95 % CI 0.47–0.92; p = 0.014). CABG was also associated with markedly lower rates of MI readmission (3.2 % vs. 23.7 %; aHR 0.11, 95 % CI 0.03–0.38; p < 0.001) and repeat revascularization (6.4 % vs. 21.6 %; aHR 0.22, 95 % CI 0.09–0.53; p = 0.001). Rates of stroke (p = 0.757) and all-cause rehospitalization (p = 0.157) were not significantly different.
Conclusions
In patients with 3VD and HF, CABG is associated with significantly improved long-term survival, reduced MI readmissions, and fewer repeat revascularizations compared to PCI. These findings reinforce the need for a multidisciplinary Heart Team review to ensure the optimal intervention strategy.
目的由于缺乏直接比较冠状动脉旁路移植术(CABG)和经皮冠状动脉介入治疗(PCI)的随机试验,三支冠状动脉疾病(3VD)合并心力衰竭(HF)患者的最佳血运重建策略仍不确定。由于很少有观察性研究提供长期随访,临床平衡仍然存在。因此,我们评估了心衰和3VD患者CABG和PCI的10年预后。方法这项基于人群的回顾性队列研究纳入了2009-2018年在加拿大艾伯塔省埃德蒙顿接受孤立CABG或PCI治疗的3VD和HF成人患者。排除STEMI患者、既往冠脉搭桥或伴随手术。主要终点是全因死亡率。次要终点包括心肌梗死(MI)、卒中、重复血运重建术和全因再住院。采用多变量Cox回归对基线特征进行调整。结果在1774例筛查患者中,632例符合纳入标准(CABG: n = 97; PCI: n = 535)。10年时,CABG组的全因死亡率(62.4%)明显低于PCI组(71.8%)(校正风险比[aHR] 0.65, 95% CI 0.47-0.92; p = 0.014)。CABG还与心肌梗死再入院率(3.2%比23.7%;aHR 0.11, 95% CI 0.03-0.38; p < 0.001)和重复血运重成率(6.4%比21.6%;aHR 0.22, 95% CI 0.09-0.53; p = 0.001)显著降低相关。卒中发生率(p = 0.757)和全因再住院率(p = 0.157)无显著差异。结论在3VD和HF患者中,与PCI相比,CABG显著提高了长期生存率,减少了心肌梗死再入院率,减少了重复血运重建。这些发现加强了多学科心脏小组审查的必要性,以确保最佳的干预策略。
{"title":"Ten-year outcomes of coronary artery bypass grafting versus percutaneous coronary intervention in patients with three-vessel disease and heart failure","authors":"Jimmy Kang , Ryaan El-Andari , Nicholas Fialka , Yongzhe Hong , Michael S. McMurtry , Jeevan Nagendran , Jayan Nagendran","doi":"10.1016/j.ahjo.2025.100659","DOIUrl":"10.1016/j.ahjo.2025.100659","url":null,"abstract":"<div><h3>Objective</h3><div>The optimal revascularization strategy for patients with three-vessel coronary artery disease (3VD) and heart failure (HF) remains uncertain due to the absence of randomized trials directly comparing coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI). With few observational studies providing long-term follow-up, clinical equipoise persists. We therefore evaluated 10-year outcomes between CABG and PCI in patients with HF and 3VD.</div></div><div><h3>Methods</h3><div>This retrospective population-based cohort study included adults with 3VD and HF undergoing isolated CABG or PCI in Edmonton, Alberta, Canada (2009–2018). Patients with STEMI, prior CABG, or concomitant procedures were excluded. The primary endpoint was all-cause mortality. Secondary endpoints included readmission for myocardial infarction (MI), stroke, repeat revascularization, and all-cause rehospitalization. Multivariable Cox regression was used to adjust for baseline characteristics.</div></div><div><h3>Results</h3><div>Of 1774 screened patients, 632 met inclusion criteria (CABG: n = 97; PCI: n = 535). At 10 years, all-cause mortality was significantly lower in the CABG group (62.4 %) compared to PCI (71.8 %) (adjusted hazard ratio [aHR] 0.65, 95 % CI 0.47–0.92; <em>p</em> = 0.014). CABG was also associated with markedly lower rates of MI readmission (3.2 % vs. 23.7 %; aHR 0.11, 95 % CI 0.03–0.38; <em>p</em> < 0.001) and repeat revascularization (6.4 % vs. 21.6 %; aHR 0.22, 95 % CI 0.09–0.53; <em>p</em> = 0.001). Rates of stroke (<em>p</em> = 0.757) and all-cause rehospitalization (<em>p</em> = 0.157) were not significantly different.</div></div><div><h3>Conclusions</h3><div>In patients with 3VD and HF, CABG is associated with significantly improved long-term survival, reduced MI readmissions, and fewer repeat revascularizations compared to PCI. These findings reinforce the need for a multidisciplinary Heart Team review to ensure the optimal intervention strategy.</div></div>","PeriodicalId":72158,"journal":{"name":"American heart journal plus : cardiology research and practice","volume":"60 ","pages":"Article 100659"},"PeriodicalIF":1.8,"publicationDate":"2025-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145467527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-30DOI: 10.1016/j.ahjo.2025.100646
Monica Rodriguez , Michele L. McCarroll , Caroline Marrs , Kamala P. Tamirisa
Pregnancy functions as a cardiopulmonary stress test, revealing underlying cardiovascular disease (CVD) or heightening future CVD risk following adverse pregnancy outcomes (APOs). Studies consistently demonstrate strong associations between APOs, higher mortality rates, and increased risk of cardiometabolic diseases in women from racial and ethnic underrepresented groups (UREG). Social determinants of health, particularly in UREGs, contribute to increasing allostatic load, potentially driving poorer pregnancy outcomes. Breastfeeding has a protective effect on allostatic load and is linked to improved maternal cardiometabolic health. In the United States, UREGs have lower rates of breastfeeding initiation, retention, and duration—potentially influenced by both cultural factors and systemic biases within healthcare. Interventions must extend beyond healthcare settings to engage key stakeholders, including community leaders and families, to create sustainable change and reduce disparities. As maternal CVD prevalence rises among UREG populations, a collaborative, multidisciplinary approach to improving breastfeeding rates is essential to improving maternal and infant health outcomes.
{"title":"Addressing maternal cardiovascular risk: The impact of lactation, adverse pregnancy outcomes, and racial disparities","authors":"Monica Rodriguez , Michele L. McCarroll , Caroline Marrs , Kamala P. Tamirisa","doi":"10.1016/j.ahjo.2025.100646","DOIUrl":"10.1016/j.ahjo.2025.100646","url":null,"abstract":"<div><div>Pregnancy functions as a cardiopulmonary stress test, revealing underlying cardiovascular disease (CVD) or heightening future CVD risk following adverse pregnancy outcomes (APOs). Studies consistently demonstrate strong associations between APOs, higher mortality rates, and increased risk of cardiometabolic diseases in women from racial and ethnic underrepresented groups (UREG). Social determinants of health, particularly in UREGs, contribute to increasing allostatic load, potentially driving poorer pregnancy outcomes. Breastfeeding has a protective effect on allostatic load and is linked to improved maternal cardiometabolic health. In the United States, UREGs have lower rates of breastfeeding initiation, retention, and duration—potentially influenced by both cultural factors and systemic biases within healthcare. Interventions must extend beyond healthcare settings to engage key stakeholders, including community leaders and families, to create sustainable change and reduce disparities. As maternal CVD prevalence rises among UREG populations, a collaborative, multidisciplinary approach to improving breastfeeding rates is essential to improving maternal and infant health outcomes.</div></div>","PeriodicalId":72158,"journal":{"name":"American heart journal plus : cardiology research and practice","volume":"60 ","pages":"Article 100646"},"PeriodicalIF":1.8,"publicationDate":"2025-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145419242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-30DOI: 10.1016/j.ahjo.2025.100661
Lanxin Feng , Xin Zhao , Shuwen Yang , Linqi Liu , Zhao Ma , Huan Zhang , Jianping Xiang , Ming Ding , Chenchen Tu , Xiantao Song , Hongjia Zhang
Background
To assess the clinical feasibility and safety of exercise magnetocardiographic stress test based on optically pumped magnetometers (OPMs).
Methods
Subjects without previous cardiovascular disease were enrolled in this study. All subjects underwent exercise electrocardiographic stress test (EST) and both rest and stress OPM-based magnetocardiography (MCG).
Results
A total of 26 healthy subjects finally enrolled in this study. None of the subjects reported chest pain, dyspnea or any other discomfort during the test. The mean interval between the completion of EST and the initiation of OPM-based MCG signal acquisition was 60.3 ± 8.4 s. One subject observed obvious deflection of magnetic field (Unstable-MCG group) during stress OPM-based MCG, whereas 25 subjects did not (Stable-MCG group). In Stable-MCG group, the rest and stress magnetocardiographic parameters were phenotypically similar (P > 0.05).
Conclusion
We demonstrated an innovative diagnostic technology with broad potential application value for diagnosing myocardial ischemia and assessed its clinical feasibility and safety. This is a critical step toward making the examination widely used in clinical practice.
{"title":"Clinical utility of the exercise optically pumped magnetocardiographic stress test in young adults: an exploratory study","authors":"Lanxin Feng , Xin Zhao , Shuwen Yang , Linqi Liu , Zhao Ma , Huan Zhang , Jianping Xiang , Ming Ding , Chenchen Tu , Xiantao Song , Hongjia Zhang","doi":"10.1016/j.ahjo.2025.100661","DOIUrl":"10.1016/j.ahjo.2025.100661","url":null,"abstract":"<div><h3>Background</h3><div>To assess the clinical feasibility and safety of exercise magnetocardiographic stress test based on optically pumped magnetometers (OPMs).</div></div><div><h3>Methods</h3><div>Subjects without previous cardiovascular disease were enrolled in this study. All subjects underwent exercise electrocardiographic stress test (EST) and both rest and stress OPM-based magnetocardiography (MCG).</div></div><div><h3>Results</h3><div>A total of 26 healthy subjects finally enrolled in this study. None of the subjects reported chest pain, dyspnea or any other discomfort during the test. The mean interval between the completion of EST and the initiation of OPM-based MCG signal acquisition was 60.3 ± 8.4 s. One subject observed obvious deflection of magnetic field (Unstable-MCG group) during stress OPM-based MCG, whereas 25 subjects did not (Stable-MCG group). In Stable-MCG group, the rest and stress magnetocardiographic parameters were phenotypically similar (<em>P</em> > 0.05).</div></div><div><h3>Conclusion</h3><div>We demonstrated an innovative diagnostic technology with broad potential application value for diagnosing myocardial ischemia and assessed its clinical feasibility and safety. This is a critical step toward making the examination widely used in clinical practice.</div></div>","PeriodicalId":72158,"journal":{"name":"American heart journal plus : cardiology research and practice","volume":"60 ","pages":"Article 100661"},"PeriodicalIF":1.8,"publicationDate":"2025-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145419186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-29DOI: 10.1016/j.ahjo.2025.100656
Xinyu Liu , Xu Zhang , Cheng Li
Background
Hypertensive heart disease (HHD) and ischemic heart disease (IHD) are major global burdens. High body mass index (BMI) is a key modifiable risk factor, but the global burden, trends, and inequalities of HHD and IHD attributable to high BMI remain poorly defined.
Methods
We analyzed Global Burden of Disease data from 1990 to 2021 across 204 countries, estimating age-standardized mortality rates (ASMRs), disability-adjusted life-year rates (ASDRs), and annual average percentage changes (AAPCs). Additional analyses included age- and sex-specific distributions, socio-demographic index (SDI) patterns, frontier and decomposition analyses, inequality metrics, and projections to 2035 using Bayesian age–period–cohort and ARIMA models.
Results
From 1990 to 2021, global ASMR and ASDR for HHD attributable to high BMI slightly increased (AAPC: 0.014 and 0.099), whereas those for IHD declined (AAPC: −0.067 and −0.751). The highest HHD burden occurred in Southern Sub-Saharan Africa, and the greatest IHD burden in Eastern Europe. Elderly females had higher HHD mortality and DALYs, while middle-aged males bore greater IHD burden. HHD inversely correlated with SDI (r = −0.5524, P < 0.001), whereas IHD showed a unimodal relationship. Decomposition highlighted aging and population growth as major contributors. Inequalities worsened for HHD but improved for IHD. Forecasts suggest continued rises in HHD and declines in IHD by 2035.
Conclusions
HHD and IHD attributable to high BMI show divergent global trends and inequality patterns, underscoring the urgent need for targeted weight management and cardiovascular risk reduction, particularly in low- and middle-SDI regions.
{"title":"Global trends and inequalities in hypertensive and ischemic heart disease attributable to high body mass index: A systematic analysis from 1990 to 2021 with projections to 2035","authors":"Xinyu Liu , Xu Zhang , Cheng Li","doi":"10.1016/j.ahjo.2025.100656","DOIUrl":"10.1016/j.ahjo.2025.100656","url":null,"abstract":"<div><h3>Background</h3><div>Hypertensive heart disease (HHD) and ischemic heart disease (IHD) are major global burdens. High body mass index (BMI) is a key modifiable risk factor, but the global burden, trends, and inequalities of HHD and IHD attributable to high BMI remain poorly defined.</div></div><div><h3>Methods</h3><div>We analyzed Global Burden of Disease data from 1990 to 2021 across 204 countries, estimating age-standardized mortality rates (ASMRs), disability-adjusted life-year rates (ASDRs), and annual average percentage changes (AAPCs). Additional analyses included age- and sex-specific distributions, socio-demographic index (SDI) patterns, frontier and decomposition analyses, inequality metrics, and projections to 2035 using Bayesian age–period–cohort and ARIMA models.</div></div><div><h3>Results</h3><div>From 1990 to 2021, global ASMR and ASDR for HHD attributable to high BMI slightly increased (AAPC: 0.014 and 0.099), whereas those for IHD declined (AAPC: −0.067 and −0.751). The highest HHD burden occurred in Southern Sub-Saharan Africa, and the greatest IHD burden in Eastern Europe. Elderly females had higher HHD mortality and DALYs, while middle-aged males bore greater IHD burden. HHD inversely correlated with SDI (<em>r</em> = −0.5524, <em>P</em> < 0.001), whereas IHD showed a unimodal relationship. Decomposition highlighted aging and population growth as major contributors. Inequalities worsened for HHD but improved for IHD. Forecasts suggest continued rises in HHD and declines in IHD by 2035.</div></div><div><h3>Conclusions</h3><div>HHD and IHD attributable to high BMI show divergent global trends and inequality patterns, underscoring the urgent need for targeted weight management and cardiovascular risk reduction, particularly in low- and middle-SDI regions.</div></div>","PeriodicalId":72158,"journal":{"name":"American heart journal plus : cardiology research and practice","volume":"60 ","pages":"Article 100656"},"PeriodicalIF":1.8,"publicationDate":"2025-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145520827","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}